skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 57,118  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Glucose remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease
Material Type:
Article
Add to My Research

Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease

The journal of clinical endocrinology and metabolism, 2021-02, Vol.106 (2), p.e520-e533 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;COPYRIGHT 2021 Oxford University Press ;The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/clinem/dgaa792 ;PMID: 33125080

Full text available

2
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
Material Type:
Article
Add to My Research

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

The New England journal of medicine, 2022-09, Vol.387 (13), p.1161-1172 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2205225 ;PMID: 36170500

Full text available

3
Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients
Material Type:
Article
Add to My Research

Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients

BMC research notes, 2019-10, Vol.12 (1), p.653-653, Article 653 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1756-0500 ;EISSN: 1756-0500 ;DOI: 10.1186/s13104-019-4492-9 ;PMID: 31601230

Full text available

4
Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro
Material Type:
Article
Add to My Research

Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro

The EMBO journal, 2015-07, Vol.34 (13), p.1759-1772 [Peer Reviewed Journal]

2015 The Authors ;2015 The Authors. ;2015 The Authors 2015 ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.201591058 ;PMID: 25908839 ;CODEN: EMJODG

Full text available

5
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Diabetes care, 2018-05, Vol.41 (5), p.1009-1016 [Peer Reviewed Journal]

2018 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-1114 ;PMID: 29483185

Full text available

6
Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
Material Type:
Article
Add to My Research

Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications

International journal of molecular sciences, 2018-10, Vol.19 (11), p.3306 [Peer Reviewed Journal]

2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 by the authors. 2018 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms19113306 ;PMID: 30355995

Full text available

7
New closed-loop insulin systems
Material Type:
Article
Add to My Research

New closed-loop insulin systems

Diabetologia, 2021-05, Vol.64 (5), p.1007-1015 [Peer Reviewed Journal]

The Author(s) 2021. corrected publication 2021 ;COPYRIGHT 2021 Springer ;The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021, corrected publication 2021 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-021-05391-w ;PMID: 33550442

Full text available

8
Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes
Material Type:
Article
Add to My Research

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes

Diabetic medicine, 2016-04, Vol.33 (4), p.497-505 [Peer Reviewed Journal]

2015 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. ;ISSN: 0742-3071 ;EISSN: 1464-5491 ;DOI: 10.1111/dme.12982 ;PMID: 26435365 ;CODEN: DIMEEV

Full text available

9
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Material Type:
Article
Add to My Research

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

The New England journal of medicine, 2019-10, Vol.381 (18), p.1707-1717 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1907863 ;PMID: 31618560

Full text available

10
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer
Material Type:
Article
Add to My Research

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer

International journal of molecular sciences, 2021-08, Vol.22 (15), p.7797 [Peer Reviewed Journal]

2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the author. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22157797 ;PMID: 34360563

Full text available

11
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Material Type:
Article
Add to My Research

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial

Diabetologia, 2020-04, Vol.63 (4), p.698-710 [Peer Reviewed Journal]

The Author(s) 2020 ;Diabetologia is a copyright of Springer, (2020). All Rights Reserved. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-019-05080-9 ;PMID: 31984443

Full text available

12
Metabolites as regulators of insulin sensitivity and metabolism
Material Type:
Article
Add to My Research

Metabolites as regulators of insulin sensitivity and metabolism

Nature reviews. Molecular cell biology, 2018-10, Vol.19 (10), p.654-672 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 1471-0072 ;EISSN: 1471-0080 ;DOI: 10.1038/s41580-018-0044-8 ;PMID: 30104701

Full text available

13
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Material Type:
Article
Add to My Research

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

Diabetologia, 2021-05, Vol.64 (5), p.1016-1029 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-021-05422-6 ;PMID: 33710398

Full text available

14
Inceptor counteracts insulin signalling in β-cells to control glycaemia
Material Type:
Article
Add to My Research

Inceptor counteracts insulin signalling in β-cells to control glycaemia

Nature (London), 2021-02, Vol.590 (7845), p.326-331 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 11, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03225-8 ;PMID: 33505018

Full text available

15
Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes
Material Type:
Article
Add to My Research

Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes

Wiley interdisciplinary reviews. RNA, 2014-09, Vol.5 (5), p.697-712 [Peer Reviewed Journal]

2014 John Wiley & Sons, Ltd. ;ISSN: 1757-7004 ;EISSN: 1757-7012 ;DOI: 10.1002/wrna.1240 ;PMID: 24944010

Full text available

16
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Material Type:
Article
Add to My Research

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

The New England journal of medicine, 2020-11, Vol.383 (21), p.2007-2017 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2006136 ;PMID: 33207093

Full text available

17
Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance
Material Type:
Article
Add to My Research

Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance

Nature communications, 2022-02, Vol.13 (1), p.735-735, Article 735 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-28039-8 ;PMID: 35136059

Full text available

18
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
Material Type:
Article
Add to My Research

Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

Diabetes care, 2020-12, Vol.43 (12), p.2991-2998 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-2550 ;PMID: 32616612

Full text available

19
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes
Material Type:
Article
Add to My Research

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes

Diabetes care, 2014-10, Vol.37 (10), p.2763-2773 [Peer Reviewed Journal]

2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Oct 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-0876 ;PMID: 25011946 ;CODEN: DICAD2

Full text available

20
Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes
Material Type:
Article
Add to My Research

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Diabetes (New York, N.Y.), 2004-06, Vol.53 (6), p.1614-1620 [Peer Reviewed Journal]

2004 INIST-CNRS ;COPYRIGHT 2004 American Diabetes Association ;Copyright American Diabetes Association Jun 2004 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/diabetes.53.6.1614 ;PMID: 15161770 ;CODEN: DIAEAZ

Full text available

Results 1 - 20 of 57,118  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (52,251)

Refine My Results

Creation Date 

From To
  1. Before 1964  (136)
  2. 1964 To 1978  (500)
  3. 1979 To 1993  (1,771)
  4. 1994 To 2009  (6,290)
  5. After 2009  (48,408)
  6. More options open sub menu

Subject 

  1. Science & Technology  (44,746)
  2. Life Sciences & Biomedicine  (39,063)
  3. Insulin  (38,492)
  4. Diabetes  (35,005)
  5. Insulin Resistance  (24,596)
  6. Humans  (21,201)
  7. Diabetes Mellitus  (20,811)
  8. Metabolism  (17,288)
  9. Male  (15,675)
  10. Animals  (13,146)
  11. Female  (13,122)
  12. Endocrinology & Metabolism  (12,681)
  13. Obesity  (11,695)
  14. Type 2 Diabetes  (11,564)
  15. Hyperglycemia  (9,985)
  16. Proteins  (9,199)
  17. Adult  (7,943)
  18. Risk Factors  (7,790)
  19. Body Mass Index  (7,623)
  20. More options open sub menu

Language 

  1. English  (56,832)
  2. Japanese  (6,163)
  3. Portuguese  (129)
  4. German  (83)
  5. Spanish  (76)
  6. French  (54)
  7. Chinese  (51)
  8. Norwegian  (49)
  9. Turkish  (40)
  10. Persian  (26)
  11. Russian  (22)
  12. Polish  (16)
  13. Korean  (16)
  14. Italian  (8)
  15. Dutch  (8)
  16. Arabic  (4)
  17. Czech  (3)
  18. Swedish  (3)
  19. Catalan  (2)
  20. Croatian  (2)
  21. More options open sub menu

Searching Remote Databases, Please Wait